Bruker (BRKR) Tops Q3 EPS by 3c, Beats on Revenues; 'FY17 EPS Guidance Above Consensus'
Bruker (NASDAQ: BRKR) reported Q3 EPS of $0.29, $0.03 better than the analyst estimate of $0.26. Revenue for the quarter came in at $435.6 million versus the consensus estimate of $414.6 million.
Fiscal Year (FY) 2017 Financial Outlook
Bruker is raising its outlook for revenue growth, non-GAAP operating margin expansion and non-GAAP EPS in fiscal year 2017 to reflect improved operating performance and updated foreign currency rates. For FY 2017, the Company now expects revenue growth of 8% to 8.5%, including organic growth of 2.5% to 3%, growth from acquisitions of approximately 4.5%, and a foreign currency tailwind of approximately 1%.
The Company now projects an increase in FY 2017 non-GAAP operating margin of 70 bps to 100 bps year-over-year, including approximately 40 bps of headwind from recent acquisitions. Finally, for FY 2017 Bruker now expects non-GAAP EPS of $1.17 to $1.20.
Bruker sees FY2017 EPS of $1.17-$1.20, versus the consensus of $1.12.
For earnings history and earnings-related data on Bruker (BRKR) click here.